*Xist* is an X-linked noncoding RNA gene responsible for the cis induction of mammalian X chromosome inactivation (XCI) \[[@r1], [@r2]\]. To equalize X-linked gene dosage between male and female mammals, *Xist*-triggered imprinted and random XCI only occur in females but not in males during normal development \[[@r3],[@r4],[@r5]\]. Therefore, normal *Xist* expression is vital for mammalian development.

In cloned mammalian embryos or animals generated by somatic cell nuclear transfer (SCNT), the *Xist* gene exhibits an aberrant expression pattern \[[@r6],[@r7],[@r8],[@r9],[@r10],[@r11]\]. The ectopic expression of the *Xist* gene on the putative active X chromosome was observed in both male and female mouse SCNT embryos, which resulted in a large-scale downregulation of X-linked genes resembling XCI \[[@r11]\]. Suppression of aberrant *Xist* expression by deletion of the *Xist* allele on the putative active X chromosome not only abolished the dysregulation of X-linked genes, but also resulted in an eight- to nine-fold increase in full-term developmental efficiency of mouse SCNT embryos \[[@r11]\]. Inhibition of erroneous *Xist* expression in early cloned male mouse embryos via injection of *Xist*-specific small interfering RNA (siRNA) resulted in a 10-fold improvement of cloning efficiency \[[@r12]\].

Previous studies suggested that maternal *Xist* alleles are aberrantly activated in cloned pig embryos or fetuses because they have a significantly higher *Xist* mRNA level than *in vivo* fertilization-derived counterparts \[[@r13], [@r14], [@r27]\]. Suppression of aberrant *Xist* expression by knockout of *Xist* significantly enhanced the developmental competence of cloned male pig embryos \[[@r27]\]. However, the injection of anti-*Xist* siRNA into one-cell-stage male pig SCNT embryos resulted in only a slight increase in the developmental ability of injected SCNT embryos \[[@r14]\]. This is because the blocking effect of injected siRNA on *Xist* expression could not be maintained beyond the morula stage (at 5 days post-activation), at which *Xist* starts to be ectopically activated in cloned pig embryos \[[@r14]\].

Short hairpin RNA (shRNA) expression plasmid-based RNA interference (RNAi) can provide more persistent and stable gene silencing than siRNA-mediated RNAi \[[@r15],[@r16],[@r17],[@r18]\]. To investigate a more effective method to repress ectopic expression of *Xist* and to improve pig cloning efficiency, in this study, we (i) compared the silencing effect of shRNA and siRNA on *Xist* expression in cloned male pig embryos, and (ii) investigated the effects of these two *Xist* knockdown methods on the developmental competence of male pig SCNT embryos.

Materials and Methods {#s1}
=====================

Ethics statements
-----------------

This study was performed in strict accordance with the regulations of the Instructive Notions with Respect to Caring for Laboratory Animals issued by the Ministry of Science and Technology of China. The animal experiment protocol was approved by the Institutional Animal Care and Use Committee of South China Agricultural University. All efforts were made to minimize the suffering of the tested animals.

Preparation of siRNAs and chemically modified siRNA
---------------------------------------------------

Three siRNA duplexes were designed according to the cDNA sequence of porcine *Xist* gene and synthesized by the GenePharma Company (Suzhou, China). Their sequences are shown in [Table 1](#tbl_001){ref-type="table"}Table 1.Sequences of three designed siRNA duplexes targeting porcine *Xist* geneSense strandAntisense strandsiRNA15′- GCAUCUGACUGUUAUGUUUTT -3′5′- AAACAUAACAGUCAGAUGCTT -3′siRNA25′- GCAUGUGCCCUCGUGAUAATT -3′5′- UUAUCACGAGGGCACAUGCTT -3′siRNA35′- CCACAAGACUGUUAAGUUUTT -3′5′- AAACUUAACAGUCUUGUGGTT -3′Table 2.Effects of injection of anti-*Xist* siRNA1 and anti-*Xist* shRNA on the *in vitro* developmental efficiency of cloned male pig embryosTotal no. of\
activated cloned embryosTotal no. of\
cleaved cloned embryos\
(two-cell stage)Injection groupsRepetition\
no.No. of injected\
two-cell-stage embryosNo. of blastocyst/\
blastocyst rate (%)No. of cells per blastocyst1809721Control (water)414825/15.53 ± 5.0134.57 ± 1.24 (n = 10)siRNA1 (5 µM)39615/15.94 ± 5.7535.86 ± 3.91 (n = 10)siRNA1 (50 µM)310116/16.31 ± 7.7136.33 ± 1.71 (n = 10)ShRNA (5 ng/µl)413740/28.78 ± 4.59 ^§^40.59 ± 1.68 ^\*\*^ (n = 10)ShRNA (10 ng/µl)313734/24.10 ± 3.5239.56 ± 1.91 ^\*^ (n = 10)^\*^ and ^\*\*^ represent significant difference at P \< 0.05 and P \< 0.01, respectively, compared with the control group. ^§^ represents statistical difference at P = 0.079 (close to 0.05) compared with the control group.. Chemically modified siRNA1 (CM-siRNA1) and negative control siRNA (NC-siRNA) were synthesized by GenePharma Company as well. The anti-Xist siRNA was modified by two types of chemical modifications, including 5'-Chol modification at the 5' end of the sense strand and 2'-OMe modification at position 2 of the antisense strand.

Construction of shRNA expression plasmid
----------------------------------------

An anti-porcine *Xist* shRNA fragment was synthesized in accordance with the sequences of anti-*Xist* siRNA1 and inserted into multiple cloning sites between *Bbs*I and *Bam*HI of the supersilencing™ shRNA expression plasmid (GenePharma Company) to generate the pU6-shRNA plasmid ([Fig. 3](#fig_003){ref-type="fig"}Fig. 1.Screening of effective anti-*Xist* siRNA. A: Target sites of three designed anti-*Xist* siRNAs on porcine *Xist* gene. B: Inhibition of *Xist* expression in female pig kidney cells transfected with three different siRNAs at 48 h post-transfection. \*\* represents that the mean value calculated from three replicates is significantly different from that of the NC-siRNA group at P \< 0.01.Fig. 2.Inhibition of *Xist* expression in female pig kidney cells at different time points after transfection with anti-*Xist* siRNA1 and CM-siRNA1. \* and \*\* represent that the mean values calculated from three replicates are significantly different from that of the NC-siRNA group at P \< 0.05 and P \< 0.01, respectively.Fig. 3.Construction of anti-*Xist* shRNA expression plasmid. A: Structural illustration of anti-*Xist* shRNA expression plasmid. B: Partial sequencing results of anti-*Xist* shRNA expression plasmid.).

Transfection
------------

Female porcine kidney (PK-21) cells were grown at 37°C in Dulbecco's modified Eagle medium (Gibco, Grand Island, NY) containing 10% fetal bovine serum (Gibco). The PK-21 cells were seeded into 24-well plates at a density of 0.5--2.0 × 10^5^ cells/well with fresh medium (500 µl/well) without antibiotics, 24 h prior to transfection.

The PK-21 cells were transfected with siRNA/CM-siRNA (40 pmol) or pU6-shRNA plasmid (40 pmol) using Lipofectamine RNAi MAX Reagent (Invitrogen, Carlsbad, CA) in accordance with the manufacturer's instructions.

Real-time quantitative PCR (qPCR)
---------------------------------

The total RNA was isolated from the transfected cells or microinjected embryos using an RNeasyPlus Micro Kit (Qiagen, Gaithersburg, MD). The cDNA was synthesized using a PrimeScript RT Reagent Kit with gDNA Eraser (TaKaRa, Tokyo, Japan). SYBR Premix Ex Taq (TaKaRa) and Eco™ Real-time PCR system (Illumine, San Diego, CA) were used for qPCR. All PCR runs were performed at an annealing temperature of 60°C for 50 cycles. The sequences of the primers used in this study are shown in [Table 3](#tbl_003){ref-type="table"}Table 3.Sequences of the primers used for real-time qPCRGene nameForward primersReverse primers*Xist*5′-CTTGCCGCAATCGAAAACAT-3′5′-ACCAATTCCACCACCCTTTC-3′*Clic2*5′-GGGCTGTAACCTCTTTGCCA-3′5′-AACCGTGAGTTCCTCAGCAC-3′*Tbliy*5′-TGCAGCACGGACATGTGTAT-3′5′-GTTCCAGCACACCTCGAAGA-3′*Tlr7*5′-CTGGAGGCATTCCCACCAAT-3′5′-GCTGGAGTGATGCTCGCTAT-3′*Las1l*5′-AAGGTGCAGAGCTGGATGTC-3′5′-AGCAGTTCTCGGGCTCTTTC-3′*Tsr2*5′-CTGCAGAGGAGTCTCTAACGC-3′5′-GTGGCGGAACATGGTCTGTA-3′*Gapdh*5′-TGACCCCTTCATTGACCTCC-3′5′-CTCCGCCTTGACTGTGCC-3′*β-actin*5′-CCACGAGACCACCTTCAACTC-3′5′-TGATCTCCTTCTGCATCCTGT-3′.

Somatic cell nuclear transfer
-----------------------------

The male SCNT embryos were produced as previously described \[[@r19]\]. Briefly, porcine ovaries were purchased from the Guangzhou Tianhe slaughterhouse located at Tianhe District, Guangzhou City, Guangdong Province, China. Cumulus--oocyte complexes (COCs) were aspirated from the ovaries and matured *in vitro* for 42--44 h. Matured COCs were freed from cumulus cells by repeated pipetting in 0.10% hyaluronidase. *In-vitro*-matured oocytes with the first polar body were selected for enucleation. The mature oocyte was aspirated firmly into a holding pipette (outer diameter = 100--120 µm, inner diameter = 20--30 µm) to ensure immobility. The enucleation pipette (inner diameter = 15 µm) was inserted through the zona pellucida. The first polar body and adjacent cytoplasm, which were presumed to contain the entire chromosome, were aspirated into the enucleation pipette. After the fibroblast cells were digested with trypsin, a single fibroblast cell was separated by pipetting and then microinjected into the perivitelline space of the oocytes. The oocyte--donor cell complexes were cultured in PZM3 at 39°C, 5% CO~2~, 5% O~2~, 90% N~2~, and 100% humidity for 1.5 h. The cell complexes were activated to fuse in a medium containing 250 mM of mannitol, 0.1 mM of CaCl~2~·2H~2~O, 0.1 mM of MgCl~2~·6H~2~O, 0.5 of mM HEPES, and 0.01% polyvinyl alcohol through two successive abbr (DC) pulses each at 1.2 kV/cm for 30 µsec using an electrofusion instrument (model: CF-150/B, Biological Laboratory Equipment Maintenance and Service, Budapest, Hungary). The activated cloned embryos were then cultured in PZM3 containing cytochalasin B (5 µg/ml) for 4 h. After the post-activation treatment, the reconstructed embryos were cultured in PZM3 at 39°C, 5% CO~2~, 7% O~2~, 88% N~2~, and 100% humidity.

Microinjection
--------------

Microinjections of shRNA plasmid and siRNA1 were performed using a micropipette driven by the Piezo (PiezoXpert, Eppendorf, Germany). Ten picoliters of 5 or 50 µM siRNA and 5 ng/µl or 10 ng/µl anti-*Xist* shRNA plasmid was injected into the cytoplasm of each blastomere of two-cell-stage SCNT embryos. Control SCNT embryos were injected with 10 pl of water (Sigma, St. Louis, MO, USA). The injected embryos were cultured *in vitro* in PZM3 at 39°C, 5% CO~2~, 7% O~2~, 88% N~2~, and 100% humidity.

Immunofluorescence
------------------

Injected male pig embryos were collected at the blastocyst stage, washed 3--5 times in PBS, and fixed in Immunol Staining Fix Solution (Beyotime Biotechnology Company, Shanghai, China) for 15 min by incubation at 25°C. After permeabilization using Immunostaining Permeabilization Buffer with Triton X-100 (Beyotime Biotechnology Company) for 30 min, the embryos were blocked in the Immunol Staining Blocking Buffer (Beyotime Biotechnology Company) for 1 h at room temperature and washed 3--5 times followed by an overnight incubation at 4°C with primary antibodies against H3K27me3 (1:200; Thermo Fisher Scientific, Waltham, MA, USA A15024). After 3--5 washes with PBS, the embryos were incubated at room temperature and shielded from light for 1 h with Goat anti-Rabbit IgG (H + L) Cross-Adsorbed Secondary Antibody (1:500; Thermo Fisher Scientific, A11008). After washing 3--5 times in PBS, DNA staining was performed using DAPI (Thermo Fisher Scientific) for 5 min at room temperature and shielded from light. After washing, the embryos were mounted on glass slides and observed using an inverted fluorescence microscope (Nikon, Tokyo, Japan).

Statistical analysis
--------------------

Data were analyzed using the SPSS software version 20 (SPSS, Chicago, IL, USA). The relative transcription levels determined by qPCR were analyzed by the Student's *t*-test for comparing group means. One-way ANOVA followed by Tukey's post hoc test was performed to determine the difference between the developmental rates of five groups of microinjected SCNT embryos. The average number of cells per blastocyst and the blastocyst rates were reported as the mean ± standard error of the mean. A P value less than 0.05 was considered statistically significant.

Results {#s2}
=======

Three siRNAs targeting porcine *Xist*, namely siRNA1, siRNA2, and siRNA3, were designed and synthesized. Their sequences and target sites are shown in [Table 1](#tbl_001){ref-type="table"} and [Fig. 1A](#fig_001){ref-type="fig"}, respectively. The qPCR results demonstrated that all three *Xist*-targeted siRNAs effectively suppressed pig *Xist* expression at 48 h after transfection into female PK21 cells, and that siRNA1 was the most effective siRNA for blocking *Xist* expression level by over 85% ([Fig. 1B](#fig_001){ref-type="fig"}). Therefore, siRNA1 and CM-siRNA1 were used for the subsequent experiments.

The qPCR results demonstrated that in transfected female PK-21 cells, siRNA1 and CM-siRNA1 maintained their inhibitory effects on *Xist* expression for at least 3 and 1 days, respectively but lost their silencing effects on *Xist* expression before 5 and 3 days post-transfection, respectively ([Fig. 2](#fig_002){ref-type="fig"}). This finding suggests that the injection of siRNA1 or CM-siRNA1 into one-cell-stage cloned male pig embryos could not suppress the ectopic activation of *Xist* from the morula to blastocyst stage (at 5 to 7 days post-activation).

To develop a more effective *Xist* knockdown method, a plasmid called pU6-shRNA, which expresses anti-*Xist* siRNA1-derived shRNA, was constructed ([Fig. 3](#fig_003){ref-type="fig"}). This plasmid effectively blocked *Xist* transcription for over 5 days after transfection into female PK-21 cells ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Inhibition of *Xist* expression in female pig kidney cells at different time points after transfection with anti-*Xist* shRNA expression plasmid. \* and \*\* represent that the mean values calculated from three replicates are significantly different from that of the NC-shRNA group at P \< 0.05 and P \< 0.01, respectively.). This result indicates that shRNA vector-mediated RNAi has a longer silencing action on *Xist* expression than siRNA-based RNAi in pig cells.

To compare the effects of injecting anti-*Xist* siRNA1 and shRNA on *Xist* expression in pig SCNT embryos, 5 ng/µl of pU6-shRNA plasmid, 10 ng/µl of pU6-shRNA plasmid, 5 µM of siRNA1, and 50 µM of siRNA1 were injected into two-cell-stage cloned male pig embryos. Two groups of SCNT embryos injected with anti-*Xist* siRNA1 did not show a decrease in *Xist* mRNA level but an increase of 4 X-linked gene mRNA levels at the blastocyst stage compared with the control SCNT embryos injected with water ([Fig. 5A](#fig_005){ref-type="fig"}Fig. 5.Effects of injection of anti-*Xis*t siRNA1 (A) and anti-*Xist* shRNA (B) on the expression of *Xist* and four randomly selected *X*-linked genes at the blastocyst stage of injected cloned male pig embryos. The mRNA levels of each injection group were measured from a mixture of 10 to 20 embryos collected at the blastocyst stage (168 h post-activation). The mRNA levels of the 5 or 50 μM siRNA1-injected and 5 or 10 ng/μl shRNA-injected groups were normalized to that of the control group, which was defined as 1. \* and \*\* represent that the mean values calculated from three replicates are significantly different from that of the control group at P \< 0.05 and P \< 0.01, respectively.). This finding suggests that siRNA1 failed to block *Xist* expression and upregulate X-linked gene expression at the blastocyst stage of the injected cloned male pig embryos. However, the injections of 5 and 10 ng/µl of pU6-shRNA plasmid into cloned male pig embryos resulted in an almost significant (P = 0.07) and significant decrease in *Xist* transcription level at the blastocyst stage, respectively ([Fig. 5B](#fig_005){ref-type="fig"}). Furthermore, the expression levels of 4 X-linked genes in the two groups of SCNT embryos injected with pU6-shRNA plasmid were significantly elevated at the blastocyst stage. These results imply that the injection of pU6-shRNA plasmid into cloned male pig embryos can rescue abnormal XCI by suppressing *Xist* expression at the blastocyst stage.

To further compare the effects of injecting anti-*Xist* siRNA1 and shRNA on XCI in pig SCNT embryos, we performed an immunofluorescence analysis of H3K27me3, which is a marker of XCI, on control, 50 µM anti-Xist siRNA-injected, and 5 ng/µl anti-Xist shRNA plasmid-injected cloned male pig blastocysts. The results showed that in all three groups, approximately half of the cloned male pig blastocysts displayed one inactive X chromosome (Xi) signal in their nuclei ([Fig. 6](#fig_006){ref-type="fig"}Fig. 6.Effects of injection of anti-*Xist* siRNA and anti-*Xist* shRNA expression plasmid on XCI in cloned male pig blastocysts. A: Immunostaining of an XCI marker H3K27me3 (green) in DAPI (blue)-stained nuclei of injected cloned male pig embryos at the blastocyst stage. B: Percentage of blastomeres with one Xi or without Xi at the blastocyst stage of analyzed injected male pig embryos.). The average percentages of blastomeres with one Xi signal in control, 50 µM anti-Xist siRNA-injected, and 5 ng/µl anti-Xist shRNA plasmid-injected male pig blastocysts were 15.1%, 10.3%, and 4.3%, respectively ([Fig. 6](#fig_006){ref-type="fig"}). This suggests that the injection of anti-Xist shRNA expression plasmid can inhibit ectopic X chromosome inactivation in cloned male pig embryos. Moreover, our results indicated that in 12 analyzed cloned male pig blastocysts from the control group, only five blastocysts exhibited one Xi signal; furthermore, in these five Xi signal-positive blastocysts, only 15.1% of blastomeres showed one Xi signal ([Fig. 6](#fig_006){ref-type="fig"}). The low occurrence of XCI in cloned male pig blastocysts could be attributed to the initiation but incomplete XCI at the blastocyst stage of pig embryos, which has been reported in some studies \[[@r28],[@r29],[@r30]\].

Cloned male pig embryos injected with 5 and 10 ng/µl of pU6-shRNA plasmid showed a significantly higher cell number per blastocyst than the control cloned embryo injected with water ([Table 2](#tbl_002){ref-type="table"}). The blastocyst rate exhibited an upward trend (P = 0.079) in 5 ng/µl of pU6-shRNA plasmid-injected cloned male embryos compared with that in the control embryos ([Table 2](#tbl_002){ref-type="table"}). Nevertheless, anti-*Xist* siRNA1-injected cloned embryos exhibited a similar cell number per blastocyst and blastocyst rate with control embryos ([Table 2](#tbl_002){ref-type="table"}). These results indicate that the *in vitro* developmental competence of cloned male pig embryos can be improved by the injection of anti-*Xist* shRNA expression vector but not by that of anti-*Xist* siRNA1 at the two-cell stage.

Discussion {#s3}
==========

In this study, we demonstrated that the injection of anti-*Xist* siRNA1 and CM-siRNA1 could not increase the *in vitro* developmental ability of cloned male pig embryos because the duration of action of injected anti-*Xist* siRNA1 and CM-siRNA1 was shorter than 5 days. Similar results have been reported in a previous study \[[@r14]\]. In addition, other studies indicated that the inhibitory effects of siRNAs on target gene expression lasted for only 2 to 5 days \[[@r20],[@r21],[@r22]\]. Although CM siRNAs generally have a prolonged silencing effect on target gene expression compared with non-CM siRNA, they were less effective than non-CM siRNAs \[[@r23], [@r24]\] in some studies, as discovered in this study. Chemical modifications can improve the resistance to enzymatic digestion and thermal stability for siRNA; nonetheless, they could negatively affect the functions of siRNA by changing the conformation of siRNA.

We demonstrated that the blocking action of plasmid-expressed shRNA on *Xist* expression lasted for over 5 days. This is consistent with the findings of other studies where shRNA expressed from vectors can provide a longer duration of gene silencing than siRNAs \[[@r15], [@r16]\]. The prolonged gene silencing effect of plasmid-expressed shRNA may be due to the higher stability of plasmid and/or shRNA than siRNA in living cells \[[@r25], [@r26]\].

The prolonged silencing effect of injected anti-*Xist* shRNA expression plasmid might be the primary reason for the significant suppression of *Xist* transcription at the blastocyst stage and for the significant improvement of developmental indexes of injected cloned male pig embryos. However, the injection of shRNA expression plasmid into cloned embryos at the two-cell stage, instead of at the one-cell stage, might have also contributed to effective blockage of *Xist* expression at the blastocyst stage and the improvement in developmental efficiency of the injected cloned embryos.

Suppression of ectopic *Xist* activation and enhancement of developmental efficiency of cloned pig embryos can also be achieved by the knockout of the maternal *Xist* allele in nuclear donor cells \[[@r27]\], similar to that in cloned mouse embryos \[[@r11]\]. Nevertheless, mutation of the *Xist* gene in cloned embryos results in inheritable genetic modifications, which are undesired in most cases, especially when wild-type cloned embryos or animals are required for subsequent use. If the RNAi-based knockdown of *Xist* and the knockout of *Xist* have a similar effect on increasing cloning efficiency, the former method is more favorable because it does not mutate the *Xist* gene. However, the RNAi-based method is disadvantageous because it can only enhance the developmental competence of male but not female mouse SCNT embryos \[[@r28]\], whereas the knockout of maternal *Xist* allele can improve the developmental efficiency of both male and female mouse SCNT embryos \[[@r11]\]. Interestingly, a recent study reported that a new method via the epigenetic modification of the *Xist* gene can increase the developmental ability of mouse embryos \[[@r31]\].

In summary, *Xist* expression at the blastocyst stage is inhibited and developmental ability is enhanced in cloned male pig embryos by injecting anti-*Xist* shRNA expression plasmid but not by injecting anti-*Xist* siRNA at the two-cell stage. This finding indicates that vector-based RNAi rather than siRNA-mediated RNAi of *Xist* can be used to improve pig cloning efficiency.
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